Leading Companies Enhancing Their Presence in the Assisted Reproductive Technology Market

The assisted reproductive technology (ART) sector is on track for significant expansion over the coming years, driven by innovations and rising demand in fertility treatments. As technology advances and healthcare investments increase, this market is set to play a vital role in addressing infertility and improving reproductive outcomes worldwide. Let's explore the key aspects shaping this dynamic market, including its size, leading players, trends, and major segments.

Projected Growth and Market Value of Assisted Reproductive Technology by 2030
The ART market is expected to reach a substantial size of $56.96 billion by 2030, growing at a compound annual growth rate (CAGR) of 8.9%. This robust growth is fueled by several important factors such as the wider adoption of precision fertility diagnostics, increased investment in fertility treatment infrastructure, the expanding use of genetic testing in reproductive procedures, and a growing preference for minimally invasive treatment options. Additionally, rising healthcare expenditures dedicated to reproductive health are contributing to this upward trajectory. Leading trends over this period include greater use of advanced embryo screening techniques, the growing popularity of frozen embryo and egg banking, a focus on personalized fertility treatments, and enhanced genetic testing applications aimed at boosting treatment success rates.

Download a free sample of the assisted reproductive technology market report:
https://www.thebusinessresearchcompany.com/report/assisted-reproductive-technology-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Apr_PR

Major Companies Driving the Assisted Reproductive Technology Market
Several prominent players are actively shaping the ART market landscape. Key companies include Cooper Surgical Inc., Ferring Pharmaceuticals Ltd., Hamilton Thorne Ltd., Merck KGaA, Genea Limited, California Cryobank, European Sperm Bank, OvaScience Inc., Bloom IVF Centre, Vitrolife AB, FUJIFILM Irvine Scientific Inc., Nidacon International AB, Monash IVF Group Ltd., Cook Medical, INVO Bioscience Inc., Thermo Fisher Scientific Inc., Anecova Sa, Carolinas Fertility Institute, Microm Ltd., Inception Sciences Inc., Progyny Inc., Oxford Gene Technology IP Ltd., IVI-RMA Global, Boston IVF, CARE Fertility Group, Virtus Health, Reproductive Medicine Associates of New York, Shady Grove Fertility, CCRM Fertility, New Hope Fertility Center, Houston Fertility Institute, Pacific Fertility Center, RMA of New Jersey, Sher Fertility Institute, IVF Florida, ORM Fertility, HRC Fertility, Arizona Center for Reproductive Endocrinology & Infertility, San Diego Fertility Center, and Fertility Centers of Illinois.

A notable development occurred in November 2023 when CooperCompanies, a US-based medical device manufacturer, completed the acquisition of Cook Medical's Reproductive Health division for $300 million. This acquisition enhances CooperSurgical's existing portfolio of fertility and women's health products, strengthening its position as a leading global provider in assisted reproductive technology. Cook Medical is a recognized US supplier in the ART space.

View the full assisted reproductive technology market report:
https://www.thebusinessresearchcompany.com/report/assisted-reproductive-technology-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Apr_PR

Emerging Trends Highlighted by Innovations in Assisted Reproductive Technology
The assisted reproductive technology field is witnessing rapid innovation, particularly through the development of next-generation sequencing (NGS)-based testing kits. These advanced tools are revolutionizing chromosomal analysis by improving embryo selection processes and boosting the overall success rates of fertility treatments. NGS-based preimplantation genetic testing (PGT) enables comprehensive detection of chromosomal abnormalities in embryos, supporting more informed decisions during IVF and ICSI procedures.

For example, in July 2023, Thermo Fisher Scientific Inc., a biotechnology company based in the United States, launched two cutting-edge products: the Ion ReproSeq PGT-A Kit and the Ion AmpliSeq Polyploidy Kit. These kits are designed for preimplantation genetic testing for aneuploidy (PGT-A) and are compatible with the Ion Torrent Genexus Integrated Sequencer. This platform streamlines the workflow from sample preparation to chromosomal analysis. The new kits facilitate better detection of chromosomal abnormalities, improve pregnancy outcomes, and contribute to healthier future generations. The Genexus system further simplifies research by integrating templating, sequencing, and data interpretation, while the Ion AmpliSeq Polyploidy Panel kit enhances quality control by detecting sample contamination, avoiding mix-ups, and identifying triploidy in embryos. These advancements reflect ongoing technological progress within the ART market.

Key Segments Influencing Growth in the Assisted Reproductive Technology Market
The ART market is broadly segmented into diagnosis, procedure type, and end-user categories, each with further subcategories:

1) Diagnosis:
- Hysterosalpingography (HSG), including X-ray HSG and Sonohysterography (SHG)
- Ovarian Reserve Testing, including Follicle Stimulating Hormone (FSH) Testing, Anti-Müllerian Hormone (AMH) Testing, and Antral Follicle Count (AFC) via Ultrasound
- Genetic Testing, including Preimplantation Genetic Testing (PGT), Carrier Screening Tests, and Genetic Compatibility Testing

2) Procedure Type:
- Fresh Non-Donor
- Fresh Donor
- Frozen Donor
- Frozen Non-Donor
- Embryo or Egg Banking

3) End-User:
- Hospitals
- Fertility Clinics
- Other End-Users

These segments collectively drive the development and adoption of ART solutions, helping to meet the diverse needs of patients and healthcare providers worldwide.

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.